Wednesday May 15, 2024
Wednesday May 15, 2024

hemophilia A

$2.9 million gene therapy for severe hemophilia

Jul 1, 2023
U.S. officials on Thursday approved drugmaker BioMarin’s gene therapy for the most common form of hemophilia.

Recent News

12 hours ago

weather update

Nepalnews
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,


Newsroom
##

E-mail
[email protected]

Social Media

Exploration

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal